Ensemble

COVID-19 Vaccine Study

Main objective:

This study will be enrolling pregnant women to receive an investigational vaccine intended to evaluate the safety, reactogenicity and immunogenicity of AD26.COV2.S in newborns.

Who are we looking for?

  • 20-36 weeks of pregnancy
  • No major health problems in mother/fetus
  • Interested in possible reduction of chance of COVID-19 in baby
  • Willing to have infant followed for first year of life

What’s provided for duration of study:

  • Investigational vaccine administered to mother
  • Close follow-up of infant for 1 year
  • Modest payments for visits pre/post birth
  • Opportunity to help reduce incidence of COVID-19

If you would like additional information, please send us an email or give us a call!

Call:  334-504-7014

Thank you for your interest – we look forward to hearing from you!